USPTO serial 50151499
ZIMRALIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with ZIMRALIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Naples, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert L. Powley
Robert L. Powley Powley & Gibson, P.C.60 Hudson StreetSuite 2203New York, NY 10013Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for reducing the risk and treatment of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; Pharmaceutical preparations for the treatment of prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE); Pharmaceutical preparations for the treatment of deep vein thrombosis and pulmonary embolism and for the reduction in the risk of recurrent deep vein thrombosis and pulmonary embolism. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 8, 2026 | NWAP | NEW APPLICATION ENTERED | — |